Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Gut
|
September 16, 2008
Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
Norberto C Chavez-Tapia, Claudio Tiribelli
Annals of Hepatology
|
February 21, 2014
Clinical decisions in hepatology: the pirfenidone case analysis
Norberto C Chavez-Tapia, Nahum Méndez-Sánchez
Annals of Hepatology
|
January 19, 2025
The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
Valeria Michelle Fernández-Garibay, Norberto C Chavez-Tapia
BMC Gastroenterology
|
March 3, 2012
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
Norberto C Chavez-Tapia, Natalia Rosso, Claudio Tiribelli
Annals of Hepatology
|
November 17, 2025
Clinical and molecular implications of antipsychotics in MASLD
Celina Gonzalez, Misael Uribe, Norberto C Chavez-Tapia
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
February 19, 2004
[New molecular features of cholestatic diseases of the liver]
Nahum Méndez-Sánchez, Norberto C Chavez-Tapia, Misael Uribe
Annals of Hepatology
|
October 25, 2006
Pregnancy and gallbladder disease
Nahum Mendez-Sanchez, Norberto C Chavez-Tapia, Misael Uribe
The New England Journal of Medicine
|
March 14, 2007
Pioglitazone in nonalcoholic steatohepatitis
Norberto C Chavez-Tapia, Tonatiuh Barrientos-Gutierrez, Misael Uribe
Annals of Internal Medicine
|
March 8, 2006
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
Norberto C Chavez-Tapia, Nahum Mendez-Sanchez, Misael Uribe
Frontiers in Bioscience : a Journal and Virtual Library
|
April 18, 2003
The role of dietary fats in the pathogenesis of gallstones
Nahum Méndez-Sánchez, Norberto C Chavez-Tapia, Misael Uribe
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Gut
|
September 16, 2008
Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
Norberto C Chavez-Tapia, Claudio Tiribelli
Annals of Hepatology
|
February 21, 2014
Clinical decisions in hepatology: the pirfenidone case analysis
Norberto C Chavez-Tapia, Nahum Méndez-Sánchez
Annals of Hepatology
|
January 19, 2025
The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
Valeria Michelle Fernández-Garibay, Norberto C Chavez-Tapia
BMC Gastroenterology
|
March 3, 2012
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
Norberto C Chavez-Tapia, Natalia Rosso, Claudio Tiribelli
Annals of Hepatology
|
November 17, 2025
Clinical and molecular implications of antipsychotics in MASLD
Celina Gonzalez, Misael Uribe, Norberto C Chavez-Tapia
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
February 19, 2004
[New molecular features of cholestatic diseases of the liver]
Nahum Méndez-Sánchez, Norberto C Chavez-Tapia, Misael Uribe
Annals of Hepatology
|
October 25, 2006
Pregnancy and gallbladder disease
Nahum Mendez-Sanchez, Norberto C Chavez-Tapia, Misael Uribe
The New England Journal of Medicine
|
March 14, 2007
Pioglitazone in nonalcoholic steatohepatitis
Norberto C Chavez-Tapia, Tonatiuh Barrientos-Gutierrez, Misael Uribe
Annals of Internal Medicine
|
March 8, 2006
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
Norberto C Chavez-Tapia, Nahum Mendez-Sanchez, Misael Uribe
Frontiers in Bioscience : a Journal and Virtual Library
|
April 18, 2003
The role of dietary fats in the pathogenesis of gallstones
Nahum Méndez-Sánchez, Norberto C Chavez-Tapia, Misael Uribe
Page
of 5